Heron Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:HRTX) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Cash from operating activities -3.37 M11.78 M8.87 M10.87 M-1.33 M9.18 M 27.59 M Cash from investing activities 3.97 M11.42 M2.27 M7.33 M11.86 M-5.46 M 16.01 M Cash from financing activities 14 K423 K64 K781 K13.36 M219 K 14.43 M Free cash flow -3.37 M11.78 M8.76 M10.66 M-1.33 M9.18 M 27.27 M

Notícias

Heron Therapeutics, Inc. (HRTX) Q4 2025 Earnings Call Transcript

Lucro da Heron Therapeuti veio abaixo das projeções; receita supera estimativas

Heron Therapeuti earnings missed, revenue topped estimates

Heron apresenta crescimento de 48% do ZYNRELEF no 4º tri de 2025

Heron Q4 2025 slides: acute care surge drives 48% ZYNRELEF growth

Ações da Heron Therapeutics disparam após forte crescimento de receita no Q4

Heron Therapeutics stock soars after strong Q4 revenue growth

APONVIE da Heron é destaque em novas diretrizes para náusea pós-operatória

Heron’s APONVIE featured in new postoperative nausea guidelines

Jefferies reduz preço-alvo das ações da Heron Therapeutics devido ao declínio da franquia oncológica

Jefferies lowers Heron Therapeutics stock price target on oncology franchise decline

Heron Therapeutics, Inc. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:HRTX) 2025-11-04